Meta Platforms Inc., the owner of Facebook and Instagram, will ignore some of its ethics watchdog’s advice to tighten up its oversight of drug-related posts, in a decision with widespread ramifications for how people learn about psychedelic drugs. The Oversight Board’s guidance on drugs stems from a 2022 post tagged to a “paid partner” that described a ketamine treatment as a “medicine” and a “magical entry into another dimension.” Meta removed and reinstated the post three times.
Read the article: Bloomberg
